Table 2.
Distribution of total fibrosis, focal IF/TA, and diffuse renal fibrosis among various renal pathologies.
| Renal Disease | % Total Fibrosis | % Focal IF/TA | % Diffuse Fibrosis |
|---|---|---|---|
| ANCA GN (n = 8) | 25 (12.5–45) | 15 (5–37.5) | 5 (5–10) |
| AIN (n = 7) | 30 (20–40) | 20 (7–25) | 5 (0–20) |
| Membranous GN (n = 4) | 20 (10–45) | 17.5 (10–40) | 2.5 (0–5) |
| Lupus nephritis (n = 10) | 17.5 (8.75–52.5) | 7.5 (5–31.3) | 5 (2.75–11.3) |
| Hypertension (n = 7) | 25 (10–60) | 15 (5–40) | 5 (5–20) |
| IgAN (n = 10) | 25 (5–45) | 17.5 (0.75–36.3) | 5 (2.25–12.5) |
| FSGS (n = 12) | 20 (11.3–30) | 14 (5–25) | 5 (2–10) |
| DKD (n = 9) | 50 (17.5–70) | 40 (12.5–60) | 10 (5–10) |
| p value | 0.2355 | 0.3009 | 0.0185 |
Median values and IQR are shown. The Kruskal–Wallis test was used for between groups comparison. Abbreviations: AIN—acute interstitial nephritis; ANCA—antineutrophil cytoplasmic antibody; DKD—diabetic kidney disease; FSGS—focal segmental glomerulosclerosis; GN—glomerulonephritis; IF/TA—interstitial fibrosis/tubular atrophy; IgAN—immunoglobulin A nephropathy.